Nanocomposites based on biodegradable polycaprolactone (PCL) and organically modified layered silicates (organoclay) have been prepared by melt mixing. The isothermal crystallisation of polycaprolactone/clay nanocomposites showed that the well-dispersed organoclay platelets acted as nucleating agents in the PCL matrix, as confirmed by a remarkable reduction of the crystallisation half-time t1/2. The nanocomposites showed much higher complex viscosity than that of the neat PCL and pseudosolid-like behaviour in the low frequency range. The foaming process of PCL/clay nanocomposites containing 2%wt and 5%wt of clay were investigated by using a batch process. The results showed that the presence of clay resulted in an increase in cell density and a reduction of cell size compared to pure PCL and higher densities due to the higher viscosity of the melt.
No takes yet. Share an insight, caveat, or question.
Maio et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: